Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Acta Radiol ; 46(8): 782-90, 2005 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16392602

RESUMEN

PURPOSE: To determine the diagnostic accuracy of targeted electrical impedance imaging in characterizing breast lesions, and to evaluate whether lesion size, depth and histopathology affect the diagnosis. MATERIAL AND METHODS: A total of 137 women with 145 lesions (79 malignant and 66 benign) found by palpation or mammography were prospectively enrolled in this study. The patients were examined by means of clinical breast examination, mammography, ultrasonography, and electrical impedance imaging with TransScan TS2000. A level of suspicion (LOS) post-processing algorithm (v2.67) was used for TS2000 lesion assessment. Imaging findings were correlated with cytologic (n=54) and histologic diagnoses (n=91). Patients with benign lesions were followed up for a mean of 36 months. RESULTS: TS2000 showed a high sensitivity (86%) which did not differ significantly from that of mammography (87%) and ultrasonography (US) (75%). The specificity of TS2000 (49%) was significantly lower compared to mammography (97%, P<0.0001) and US (100%, P<0.0001). The additive use of TS2000 to mammography and US yielded no significant increase in sensitivity (97%), but the decrease in specificity was significant (46%, P<0.0001). Diagnostic effectiveness of TS2000 (Az=0.68), as measured by the area under the ROC curve, was significantly lower than for mammography (Az=0.93, P<0.0001) and for US (Az=0.91, P<0.0001). When using TS2000 in addition to mammography and US (Az=0.86), a significant impairment was found (P=0.0003). CONCLUSION: The role of targeted electrical impedance imaging as an adjunct to mammography and ultrasonography in the diagnosis of breast lesions is not justified by the result of this study.


Asunto(s)
Algoritmos , Enfermedades de la Mama/diagnóstico , Diagnóstico por Imagen/métodos , Impedancia Eléctrica , Procesamiento de Imagen Asistido por Computador/métodos , Adulto , Anciano , Anciano de 80 o más Años , Enfermedades de la Mama/patología , Enfermedades de la Mama/fisiopatología , Femenino , Estudios de Seguimiento , Humanos , Mamografía , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Reproducibilidad de los Resultados , Ultrasonografía Mamaria
2.
Acta Radiol ; 44(4): 373-8, 2003 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12846686

RESUMEN

PURPOSE: To investigate the value of pre-operative contrast-enhanced MR imaging (CE-MRI) in predicting the disease-free and overall survival in breast cancer. MATERIAL AND METHODS: The study population consisted of 50 consecutive patients with histopathologically verified primary breast cancer who pre-operatively underwent CE-MRI examination between 1992 and 1993. A three-time point MR examination was performed where the enhancement rates (C1 and C2), signal enhancement ratio (SER=C1/C2) and washout (W=C1-C2) were calculated. The relation of these MR parameters to disease-free and overall survival was investigated. The median follow-up for surviving patients was 95 months. Univariate and multivariate statistical analyses were performed to evaluate the impact of different factors on prediction of survival. RESULTS: Of the MR parameters examined at univariate analysis, increased C1 (p=0.029), W (p=0.0081) and SER values (p=0.0081) were significantly associated with shorter disease-free survival, and only C1 (p=0.016) was related significantly to overall survival. Multivariate analysis for disease-free survival showed that the SER (p=0.014) and tumor size (p=0.001) were significant and independent predictors. Age (p=0.003), lymph node status (p=0.014), tumor size (p=0.039) and proliferating cell nuclear antigen index (p=0.053) remained independently associated with overall survival at multivariate analysis. C1 was not confirmed as an independent predictor of overall survival. CONCLUSION: Our findings support the presumption that CE-MRI is useful in predicting the disease-free survival in patients with breast cancer.


Asunto(s)
Neoplasias de la Mama/mortalidad , Neoplasias de la Mama/patología , Imagen por Resonancia Magnética/métodos , Medios de Contraste , Supervivencia sin Enfermedad , Femenino , Estudios de Seguimiento , Humanos , Persona de Mediana Edad , Análisis Multivariante , Valor Predictivo de las Pruebas , Pronóstico , Análisis de Supervivencia , Factores de Tiempo
3.
Acta Radiol ; 44(4): 379-86, 2003 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12846687

RESUMEN

PURPOSE: To assess the value of kinetic and architectural diagnostic criteria on dynamic MR breast imaging, and to construct a scoring system for lesion characterization. MATERIAL AND METHODS: A total of 92 women with 109 histopathologically verified breast lesions were included in this retrospective study. The patients were examined by a 1.5 T system using a dedicated double breast coil. A dynamic examination with one precontrast and seven postcontrast series was performed, using a T1-weighted 3D FLASH sequence. Thirty lesions (15 malignant and 15 benign) were randomly chosen for the validation set, and the remaining 79 lesions (62 malignant and 17 benign) formed the estimation set, in which multivariate analysis was performed in order to select the most important features. These parameters were then used for constructing the scoring system, which was tested on the validation set. The scoring system was compared with the routine standard evaluation that used all established diagnostic criteria. ROC curves were generated to assess the diagnostic accuracy of different approaches. RESULTS: In the multivariate analysis of the 79 lesions, time-to-peak enhancement and the descriptor of margins were found to be the most important independent factors for distinguishing benign from malignant lesions, and formed the basis of the scoring system. The areas under the ROC curves for the standard evaluation, and the scoring system were 0.813 and 0.880 in the 30 lesions. CONCLUSION: Time-to-peak enhancement and the descriptor of margins appear to be the most important diagnostic criteria for mass lesions in dynamic breast MR imaging.


Asunto(s)
Neoplasias de la Mama/patología , Mama/patología , Imagen por Resonancia Magnética/métodos , Enfermedades de la Mama/patología , Medios de Contraste , Femenino , Gadolinio DTPA , Humanos , Modelos Logísticos , Persona de Mediana Edad , Curva ROC , Estudios Retrospectivos
4.
Acta Radiol ; 44(1): 28-34, 2003 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-12630995

RESUMEN

PURPOSE: To compare the diagnostic accuracy of planar 99mTc-sestamibi scintimammography with dynamic contrast-enhanced MRI (CE-MRI) on the basis of histopathologic results, and to determine the clinical value of these methods as adjuncts to mammography. MATERIAL AND METHODS: A total of 90 consecutive women with 111 histopathologically verified breast lesions were enrolled in the study. Patients underwent scintimammography and CE-MRI in addition to mammography. Each finding was classified on a BI-RADS-like five-point rating scale describing the degree of suspicion for malignancy, and all findings were correlated with the histopathological results. RESULTS: The overall sensitivity/specificity/accuracy was 85%/59%/78% for mammography, 94%/47%/80% for CE-MRI, and 82%/75%/80% for scintimammography, respectively. CE-MRI showed higher sensitivity (p = 0.008), but its specificity was lower than scintimammography (p = 0.049). Using ROC analysis, significant improvement ( p = 0.034) was found between mammography and the combination of mammography + CE-MRI, while mammography + scintigraphy showed no higher diagnostic accuracy than mammography alone. CONCLUSION: If high sensitivity and spatial resolution are needed, CE-MRI is to be preferred in clinical practice as an adjunct to mammography, rather than scintigraphy.


Asunto(s)
Neoplasias de la Mama/diagnóstico por imagen , Neoplasias de la Mama/patología , Imagen por Resonancia Magnética , Mamografía , Cintigrafía , Radiofármacos , Tecnecio Tc 99m Sestamibi , Adulto , Anciano , Anciano de 80 o más Años , Medios de Contraste , Femenino , Humanos , Persona de Mediana Edad , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Índice de Severidad de la Enfermedad
5.
Acta Histochem ; 87(2): 123-9, 1989.
Artículo en Inglés | MEDLINE | ID: mdl-2483294

RESUMEN

Distribution of the marker enzymes fluoride-resistant acid phosphatase (FRAP) and thiamine monophosphatase (TMPase) as well as that of the marker neuropeptide substance P (SP) has been mapped by means of the semi-automatic computer program MUDH, in various experimental conditions, including degeneration, regeneration, and anti-Nerve Growth Hormone treatment of the sciatic nerve. The program is written in standard Pascal language; it is applicable to Commodore 64 and IBM compatible personal computers. Graphical illustration of values obtained in serial sections is a powerful and highly valuable contribution in the analysis of various biodynamic reactions related to transganglionic regulation of primary sensory neurons.


Asunto(s)
Fosfatasa Ácida/análisis , Monoéster Fosfórico Hidrolasas/análisis , Médula Espinal/citología , Sustancia P/análisis , Animales , Femenino , Fluoruros/farmacología , Histocitoquímica , Inmunohistoquímica , Masculino , Microcomputadores , Ratas , Ratas Endogámicas , Programas Informáticos , Médula Espinal/enzimología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...